Complete remission of metastatic pancreatic cancer with cardiac involvement after gemcitabine, oxaliplatin and 46-h infusion of 5-fluorouracil/leucovorin [1]

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 6, 2004, Pages 716-717

  Wu, Wen Chih ^a,b   Chen, Shinn Cherng ^b   Su, Yu Chung ^b   Chuang, Wan Long ^b   Chen, Li Tzong ^b,c  

^a Pao Chien Hospital   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN;

ADULT; ANAMNESIS; AUTOPSY; CANCER REGRESSION; CARDIOTOXICITY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; ELECTROCARDIOGRAM; HEART INFARCTION; HUMAN; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 3042781851     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2004.03199.x     Document Type: Letter

References (6)

1. Lam KY, Dickens P, Chan ACL. Tumors of the heart. a 20-year experience with a review of 12,485 consecutive autopsies. Arch. Pathol. Lab. Med. 1993; 117: 1027-31.
2. Bowman AR, Siegel RJ, Blanche C et al. Metastatic pancreatic adenocarcinoma to the heart diagnosed antemortem. J. Am. Soc. Echocardiogr. 2000; 13: 415-16.
3. Labib SB, Schick EC Jr, Isner JM. Obstruction of right ventricular outflow tract caused by intracavitary metastatic disease: analysis of 14 cases. J. Am. Coll. Cardiol. 1992; 19: 1664-8.
4. Faivre S, Raymond E, Woynarowski JM et al. Supraadditive effect of 2′,2′-difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines. Cancer Chemother. Pharmacol. 1999; 44: 117-23.
5. Louvet C, Andre T, Hammel P et al. Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM). Ann. Oncol. 2001; 12: 675-9.
6. Louvet C, Andre T, Lledo G et al. Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. J. Clin. Oncol. 2002; 20: 1512-18.